As of 2025-12-09, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -11.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 1,794.65 mil USD. Novocure's TTM EBITDA according to its financial statements is -159.57 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 16.2x | 12.8x |
| Forward P/E multiples | 18.6x - 27.1x | 21.0x |
| Fair Price | (30.44) - (27.05) | (28.05) |
| Upside | -352.4% - -324.3% | -332.6% |
| Date | EV/EBITDA |
| 2025-12-02 | -10.45 |
| 2025-12-01 | -10.98 |
| 2025-11-28 | -11.77 |
| 2025-11-26 | -11.74 |
| 2025-11-25 | -11.65 |
| 2025-11-24 | -11.58 |
| 2025-11-21 | -11.17 |
| 2025-11-20 | -10.83 |
| 2025-11-19 | -10.82 |
| 2025-11-18 | -10.82 |
| 2025-11-17 | -10.69 |
| 2025-11-14 | -10.73 |
| 2025-11-13 | -10.77 |
| 2025-11-12 | -10.76 |
| 2025-11-11 | -11.11 |
| 2025-11-10 | -10.69 |
| 2025-11-07 | -10.45 |
| 2025-11-06 | -10.69 |
| 2025-11-05 | -10.93 |
| 2025-11-04 | -11.20 |
| 2025-11-03 | -11.37 |
| 2025-10-31 | -11.77 |
| 2025-10-30 | -11.78 |
| 2025-10-29 | -12.24 |
| 2025-10-28 | -12.17 |
| 2025-10-27 | -12.31 |
| 2025-10-24 | -12.43 |
| 2025-10-23 | -12.55 |
| 2025-10-22 | -12.51 |
| 2025-10-21 | -12.70 |
| 2025-10-20 | -12.94 |
| 2025-10-17 | -12.45 |
| 2025-10-16 | -12.63 |
| 2025-10-15 | -12.73 |
| 2025-10-14 | -12.03 |
| 2025-10-13 | -12.07 |
| 2025-10-10 | -12.25 |
| 2025-10-09 | -12.84 |
| 2025-10-08 | -12.85 |
| 2025-10-07 | -12.72 |
| 2025-10-06 | -12.96 |
| 2025-10-03 | -13.07 |
| 2025-10-02 | -12.64 |
| 2025-10-01 | -12.59 |
| 2025-09-30 | -11.85 |
| 2025-09-29 | -11.85 |
| 2025-09-26 | -11.83 |
| 2025-09-25 | -11.75 |
| 2025-09-24 | -11.79 |
| 2025-09-23 | -11.91 |